How are Rising Government Initiatives Driving Growth of Global Electronic Health Record Market?

The soaring number of government initiatives in many countries, aimed at promoting the adoption of electronic health records (EHR) in hospitals and clinics, is one of the biggest factors fuelling the adoption of this technology across the world. For instance, the Health Information Technology for Economic and Clinical Health (HITECH) Act was enacted by the U.S. government in 2009 in order to promote the incorporation of EHR systems in the healthcare settings, such as hospitals and clinics, and consequently enhance and modernize the country’s healthcare system.

Driven by the above-mentioned factors, the valuation of the global electronic health record market size is expected to increase from $22.3 billion in 2017 to $30.4 billion by 2023. The market is predicted to progress at a CAGR of 5.4% during the forecast period (2018–2023). EHR systems are widely adopted in ambulatory care centers, inpatient facilities, and physician offices. Amongst these, ambulatory care centers are expected to observe the fastest growth in the adoption of EHR systems during the forecast period, mainly due to the rising number of such medical establishments across the globe.

To Learn More About this Report: https://bit.ly/2U3nNlo

Globally, Asia-Pacific (APAC), owing to the surging geriatric population and increasing incidence of chronic diseases, is expected to observe the fastest growth in the usage of EHR systems in the years to come. As per the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), in 2016, around 12.4% of the total population of the region was aged 60 years or above. In addition to this, the surging government initiatives in the several APAC countries aimed at improving the healthcare infrastructure are expected to further fuel the growth of the EHR market in the region.

Market Segmentation by Delivery Mode

·         Web-based/cloud-based server

·         On-premise

Market Segmentation by Component

·         Practice management

·         Patient management

·         E-prescribing

·         Referral management

·         Population health management

Market Segmentation by End User

·         Inpatient

o    Acute care

o    Long term care

o    Post-acute care

·         Ambulatory care

·         Physician offices

Read More

How is Rising Usage of mHealth Driving Medication Adherence Market?

The wireless technology, especially mobile phones, are increasingly being utilized across the globe. The rising usage of mobile phones has made life easier on a lot of fronts. Communication has become easier, and now with the smart phones, people can almost do everything they can do with their computers via smartphones. In 2020, about 3.5 billion people are using smartphones, which is about 45% of the world’s population owing a smartphone. In addition to this, the total number of people across the globe who own a smart and feature phone is 4.78 billion, which is approximately 61% of the world’s population.

Request for sample copy of this report: https://bit.ly/2YZzETn

These days mobile phones, and other devices including personal digital assistances and patient monitoring devices, are also being utilized for medical and public health practices, which is also called mHealth. As per the United Nations Food and Drug Administration, about 500 million people around the world were utilizing personal healthcare applications in 2015, which was projected to grow to over 1 billion in 2018. A major application of mHealth is medication adherence, which is the degree to which the person’s behavior corresponds to the agreed recommendations from healthcare providers. Poor adherence to the prescribed regimens can lead to serious healthcare consequences. Attributed to this, the medication adherence market size is projected to witness significant growth in the coming years.

Medication adherence products are both software and hardware centric. In the past, software centric medication adherence products, including mobile apps, various web portals, and could based application, were more in demand in the past. However, the demand for hardware centric medication adherence products, including devices and packaging, are expected to advance considerably in the coming years. The reason for this is the growing focus of companies in the medication adherence market on launching hardware centric products including HealthAssist Watch by Adherence Solutions LLC, and Smart Wireless Pill Bottles by AdhereTech Inc.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-adherence

Hence, the demand for medical adherence is growing due to the rising penetration of mobile devices.

This study covers

• Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings
• Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders
• Major players operating in the market and their service offerings
• Recent strategic developments by the major players in the market

Read More

How is Surging Population Driving Agricultural Biotechnology Market?

The world’s population has grown constantly since the age of human beings began; for example, in 1800 the population across the globe was under 1 billion, which has now, almost dramatically, risen to 7.7 billion. With this surging population, the need for enhancing the productivity of everything, for catering to the requirements of the people, has increased as well. This includes the productivity in agricultural fields, of course. In the old days, the only concern of people was to somehow grow enough food for their survival, and while survival is the major concern today as well, the priorities of the human race seem to have shifted.

Request for sample copy of this report: https://bit.ly/2BvvVVt

Farming used to be the primary occupation in the past, but since the advent of industries and machines, the agricultural sector has somewhat been neglected. At the present time, however, there is a pressing need for increasing the agricultural productivity, which is why a number of technological advancements have occurred in the agricultural sector. One of such developments is the emergence of agricultural biotechnology, which involves the utilization of science for modifying animals and plants. This is done to breed out undesirable characteristics, such as low productivity and susceptibility to diseases. Furthermore, any beneficial traits can be bred in by making use of a gene which contains the specific characteristic.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=agricultural-biotechnology-market

Agricultural biotechnology helps in enhancing agricultural productivity and animal feeds, for increasing their nutrient intake and reducing environmental waste. Attributed to such positive aspects, the agricultural biotechnology market is expected to advance at a substantial rate in the coming years. The different technologies utilized in agricultural biotechnology are biochips, genome editing tools, synthetic biology, deoxyribonucleic acid (DNA) sequencing, and ribonucleic acid interference (RNAi). Out of these, genomic editing tools are used the most, primarily in agricultural research.

Hence, agricultural biotechnology is increasingly being adopted for increasing the agricultural productivity

Read More

How are Awareness Campaigns Driving Disposable Plastic Blood Bag Market?

Heart diseases kill 17.9 people each year, while 9.6 million die of cancer, says the World Health Organization (WHO). With these, the surgery and hospitalization rates are rapidly going up. One of the most basic things many such patients need is blood, which, being a highly critical and easily contaminable product, has to be kept in clean and sterile bags. Thus, with the growing incidence of chronic diseases and usage of blood at healthcare centers, the disposable plastic blood bag market size is expanding around the world. 

Disposable bags are indispensable for two main reasons: to stop blood of different groups mixing with each other, which can be deadly for the recipient, and to minimize the chances of blood-borne diseases, such as acquired immune deficiency syndrome (AIDS). Disposable bags are also used when collecting blood, and with the rate of blood donation going up, the demand for such containers is also surging. For instance, in the U.K., the number of donated units increased from 161,019 in 2015/16 to 159.264 in 2018/19, according to the National Health Service (NHS) data.

To Learn more About this report@ https://bit.ly/2Yr6HRn

Across the world, the largest disposable plastic blood bag market is North America, majorly on account of the rising number of patients suffering from blood disorders. For instance, the Leukemia and Lymphoma Society says that every three minutes, blood cancer is diagnosed in one person in the U.S. Further, according to the National Cancer Institute of the U.S., 61,780 cases of leukemia were detected in the country and 2019, and the disease resulted in 22,840 deaths.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=patient-engagement-solutions-market

Hence, as the surgery and hospitalization rates increase and more people willingly donate blood, the demand for disposable plastic bags to store it will also rise.

Read More

How is COVID-19 Pandemic Affecting Microbial Identification Market?

Infection is one of the most common causes of diseases, and several of these infections have proved a pestilence. In the current scenario, the COVID-19 epidemic is the world’s deadliest infection, killing over 340,000 people as of May 2020, since being detected in December 2019. Due to the rapidly increasing number cases and deaths, the adopted of microbial identification methods is increasing around the world, to ascertain whether someone has the virus or not, and if not, which other microbe could be causing the symptoms.

Apart from coronavirus, several other microbial infections have ran riot on the earth, including human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (HIV/AIDS), measles, polio, Zika, cholera, tuberculosis, anthrax, leprosy, dengue fever, malaria, and bubonic plague. Due to the rising prevalence of many such pathogen-borne diseases, the microbial identification market is growing rapidly across the world. Several consumables, services, and instruments and software are required to efficiently establish the presence of microorganisms in a given sample. Among them, consumables are the most widely bought around the world, as reagents, kits, media, and plates are used in every individual test, so they deplete rather quickly.

Request for sample copy of this report@ https://bit.ly/2NdEKWt

In the coming years, Asia-Pacific (APAC) would observe microbial identification market growth at the highest rate, on account of the rising incidence of infectious diseases here, primarily due to the booming population of the elderly. Due to their weakened immunological response, the geriatric population is more prone to infections, which also affect them more severely than other people. Similarly, the biotechnology and pharmaceutical sectors are also expanding in the region, which are also significant users of the various services, software, instruments, and consumables that make microbial identification possible.

Therefore, due to the rising menace of infections, presently COVID-19, as well as the expansion of the biotech, pharma, and food and beverage sectors, the adoption of microbial identification methods will keep rising.

Read more: https://www.psmarketresearch.com/market-analysis/microbial-identification-market

Read More

How is Surging Cases of COVID-19 Driving Cleanroom Consumables Market?

In the light of recent events, concerning the global healthcare crisis, the demand for new drugs all over the world is increasing day-by-day. COVID-19 has taken everyone by surprise, and even now no proper treatment is available for treating the disease. The virus has spread to every corner of the world, and millions of people have been affected by it. Medical professionals are making use of drugs that are available for other diseases to treat patients affected with COVID-19. However, continuous research & development activities are going on for developing a treatment for the novel diseases. 

Request for sample copy of this report@ https://bit.ly/3fxJF0E

The drug development process, however, is highly critical in nature and needs to be performed under predetermined conditions in order to make sure that the medicines remain free of any kind of contamination. Because of this, pharmaceutical companies make use of cleanrooms for developing drugs. Closed spaces that are specifically designed for providing control over environmental conditions, so that no microbes or dust particle enter in, are referred to as cleanrooms. A number of devices and consumables are utilized inside cleanrooms, therefore, the growing use of cleanrooms is driving the demand for these products as well. 

The global cleanroom consumables market is expected to advance at a significant pace in the years to come. A number of consumables are utilized cleanrooms, namely cleaning products (including cleaning chemicals, cleanroom mops, cleanroom swabs, and buckets, wringers, & squeegees), apparel (including sleeves, coverall, bouffant, lab coat, shoe cover, boot cover, and lab coat), wipers (including wet and dry), stationery (including labels, paper, binders & clipboards, and notebooks & adhesive pads), adhesive mats, and gloves. Out of all these, the demand for gloves was the highest in the past and the situation is expected to remain the same in the coming years as well.

Geographically, North America is projected to emerge as a major cleanroom consumables market in the near future, which is owing to the growing pharmaceutical & biotechnology industry, technological advancements, and increasing investments in research & development in the region. 

In conclusion, the demand for cleanroom consumables is increasing due to the rising incidence of COVID-19 and surging prevalence of other diseases across the globe. 

Read more: https://www.psmarketresearch.com/market-analysis/cleanroom-consumables-market

Read More

COVID-19 Impact Analysis on Infection Surveillance Solutions Market. Insights on Strategies of Key Players

The prevalence of hospital-acquired infections (HAI) has been growing rapidly, with HAIs becoming among the key cause of mortality and morbidity in hospitalized patients, as per the World Health Organization (WHO). These infections are caused primarily by bacteria. Strains of bacteria found in medical settings are more resistant to antibiotics those found outside the hospital, owing to the fact that antibiotics are utilized frequently in hospitals. According to the WHO, about 7 and 10 of every 100 patients ion developed and developing countries, respectively, who are hospitalized, acquire at least one HAI at any given time.

Attributed to this, the demand for infection surveillance at hospitals and other medical facilities is growing rapidly. Traditionally, the surveillance of HAIs was done by reviewing medical charts, ward rounds, and paper-based reports of microbiologic results. The analysis then was done by assembling hand-written data or entering the information into a computer database, manually. However, these methods are labor intensive, time-consuming, and quite inefficient for coping with the rising complexity of antibiotic resistance. Because of this, these methods are become obsolete and witnessing a shift to computer-based surveillance. Due to these factors, the global infection surveillance solutions market is predicted to advance at a considerable pace in the coming years.

To Learn more About this report@ https://bit.ly/30zsWpo

The infection surveillance technology providers offer both services and software, between which the larger demand is projected to be created for infection surveillance software in the years to come. A number of vendors are offering comprehensive and flexible infection surveillance software, which is being rapid adopted by healthcare facilities. Software can be customized for real-time and instant contact tracking tasks and effective organization surveillance. Both on-premises and web-based solutions are offered by vendors. Other than this, the demand for infection surveillance services, such as training & consulting, implementation, and product support & maintenance, is also expected to increase in the near future.

Get Detailed COVID-19 Impact Analysis on the Infection Surveillance Solutions Market: https://www.psmarketresearch.com/speak-analyst/infection-surveillance-solutions-market/Y292aWRfcXVlcnk=

Hence, the requirement for infection surveillance solutions is growing due to the rising prevalence of HAIs across the globe.

Read More

What are the Major Factors Responsible for the Boom in Saudi Arabian Surgical Sutures Market?

Due to the soaring number of surgeries and burn cases in Saudi Arabia, the demand for surgical sutures is expected to rise considerably in the coming years. Since the last few years, the prevalence of chronic diseases and other health problems has increased dramatically, and this is resulting in a huge rise in the number of surgeries being performed in the country. The other major factors pushing the demand for surgical sutures in Saudi Arabia are the surging geriatric population and rising healthcare expenditure.

To Learn more About this report@ https://bit.ly/3dPTabi

The increasing geriatric population is boosting the occurrence rate of chronic diseases and ailments, which is, in turn fuelling the growth in the demand for surgical supplies. As per the data of the Saudi government, by 2040, of the total 40 million people in the kingdom, 25% would be 60 years old or older, and by 2050, the number of the elderly will rise to around 10 million. Moreover, the burgeoning number of hospitals and medical facilities in the country, on account of the soaring healthcare expenditure, is also contributing to the increasing adoption of surgical sutures.

Due to the above factors, the Saudi Arabian surgical sutures market size is expected to grow from $16.7 million in 2017 to $20.6 million in 2023 and demonstrate a CAGR of 3.6% during the forecast period (2018–2023). There are two types of surgical sutures available in the market, namely absorbable sutures and non-absorbable sutures, of which the absorbable ones recorded higher demand in 2017. This is mainly attributed to the fact that such products do not have to be removed from the body after surgery, as they are easily broken down by the body through hydrolysis.

Get Detailed COVID-19 Impact Analysis on the Saudi Arabia Surgical Sutures Market: https://www.psmarketresearch.com/speak-analyst/saudi-arabia-surgical-sutures-market

Therefore, due to the rising number of surgeries and burn cases and burgeoning number of hospitals and other medical facilities in Saudi Arabia, on account of the surging healthcare expenditure, the demand for surgical sutures is expected to increase significantly in the coming years.

Read More

How is Rising Number of Aesthetic Surgical Procedures Driving Medical Lasers Market?

People across the globe are becoming increasingly conscious regarding their physical appearance, attributed to which the number of aesthetic surgical procedures has growing significantly in the past few years. According to the International Society of Aesthetic Plastic Surgery, 1,862,506 breast augmentation procedures were performed across the globe. In addition to this, as per the American Society of Plastic Surgeons, 17.7 million cosmetic procedures were performed in the U.S. in 2018, which was a growth of 2% from 2017. This growing number of aesthetic surgical procedures is creating increasing demand for medical lasers, as they are widely used during the surgical procedures.

 

Medical lasers are devices which make use of precisely focused light sources for treating or removing tissues. Laser stands for light amplification by stimulated emission of radiation. Ordinary light has many wavelengths and spread in all directions; laser light however has a specific wavelength, which is focused in a narrow beam and creates a very-high intensity light. Since lasers can focus on tiny areas accurately, they can be utilized for precise surgical work or for cutting tissues. If used properly, laser can allow the surgeons for accomplish more complex tasks, decrease postoperative discomfort, reduce blood loss, achieve better wound healing, and reduce the chance of wound infection.

Attributed to these factors, the global medical lasers market size is predicted to advance at a significant pace in the coming years. Different types of medical lasers are gas laser systems, solid-state laser systems, dye laser systems, and diode laser systems. Out of these, the solid-state laser systems were the most in demand in the past because of their large application base. Among the various types of solid-state laser systems, neodymium: yttrium—aluminium—garnet laser systems are extensively utilized for treating posterior capsular opacification, acute angle-closure glaucoma, peripheral iridotomy, and for surgical iridectomy.

Get Detailed COVID-19 Impact Analysis on the Medical Lasers Market: https://www.psmarketresearch.com/speak-analyst/medical-lasers-market/Y292aWRfcXVlcnk=

North America has been the largest use of medical lasers in the past, which is attributed to the rising number of cosmetic surgical procedures, high prevalence of chronic diseases and skin diseases, developed reimbursement policies, and presence of major companies in the region. Apart from this, the Asia-Pacific region is expected to emerge as the fastest growing medical lasers market in the near future, on account of increasing healthcare expenditure, rising awareness regarding technologically innovative laser treatments, and growing medical tourism in the region.

Hence, the demand for medical lasers in predicted to rise because of the increasing preference for minimally invasive surgeries and rising number of aesthetic surgeries.

Read More

Digital Health Market Projected to Register a 21.1% CAGR During Forecast Period - P&S Intelligence

The rising prevalence of chronic diseases, increasing geriatric population, and lack of primary healthcare facilities in remote areas of emerging economies are resulting in the rising requirement for remote patient monitoring services, around the world. Since aged people have low immunity levels, they are more prone to illness. Furthermore, routine check-ups, including glucose level for the management of chronic diseases and blood pressure monitoring, have led to an increase in the requirement for remote patient monitoring services. Efficient remote patient monitoring is possible with the aid of digital health platforms such as mHealth, telehealth, and others.

Digital health is a combination of healthcare services, information technology (IT), and mobile technology. Advancements in healthcare delivery practices through digital health technologies have facilitated the adoption of health information technology in healthcare facilities. As per a report by P&S Intelligence, the global digital health market size reached $73.1 billion in 2017 and is expected to generate $223.7 billion by 2023, advancing at a 21.1% CAGR during the forecast period (2018–2023). Different technologies through which digital health services are provided are healthcare analytics, mHealth, telemedicine, electronic healthcare record. The largest demand was created for the mHealth technology in 2017, which is further projected to be utilized the most during the forecast period as well.

The reason for this is the rising demand and adoption of mHealth solutions. The products and services offered by the mHealth technology are mHealth apps, connected devices, and services. Among these, the largest demand was created for connected devices during 2013–2017, and these devices are further predicted to be the most in demand during the forecast period. These devices help in lowering the cost of care and aid in real time disease management. The fastest growth in demand is projected to be witnessed by mHealth apps during the forecast period, as these apps are increasingly being utilized by people because of the rising number of health awareness programs.

Download sample copy of this report@ https://www.psmarketresearch.com/market-analysis/digital-health-market/report-sample

The surging penetration of smart phones and tablets is rising, which is driving the digital health market. As per the European Union’s press release, smart phones and mobile devices were the most used devices for accessing the internet. These devices accounted for more than 79% of the total number of internet users in 2016. Since telecommunication technology is advancing, people are adopting the latest mobile application in the healthcare sector. There are a number of mobile applications for health and fitness that help people monitor their health status. Furthermore, patients are increasingly making use of healthcare mobile apps for updating and storing their health records through tablets and smart phones.

Read More

Akt/Protein Kinase B Inhibitors Analysis, Clinical Trials and Developments

Akt/PKB inhibitors therapeutics currently exhibits a proliferating pipeline with 23 therapeutic candidates by Pharma Proff.

According to the research findings, majority of the drug candidates in the pipeline are being developed to be administered by the oral route. It has been observed that oral route of medications is convenient; available in delayed or rapid release formulation; provides improved patient’s compliance; less risk of systemic infections; and has inexpensive nature. Akt inhibitors through oral route of administration have shown positive results in the clinical studies.

The companies who are developing Akt/PKB inhibitors for the treatment of various chronic diseases have shown positive clinical results in the various phases of drug development. For instance, in June 2018, F. Hoffman-La Roche Ltd. announced the interim results of Phase II study (LOTUS) for the drug candidate, ipatasertib, that showed improvement in patients with triple negative breast cancer (TNBC) toward overall survival (OS). This result was presented in the 2018 ASCO Annual Meeting, held in the U.S. The Phase II LOTUS study showed an increase in OS up to 23.1 months (median) in interventional study, as compared to 18.4 months (median) in placebo study.

Inquiry Before Purchase this report at: https://www.pharmaproff.com/enquiry/1154

It has been observed that many pharmaceutical companies are leveraging new and improved technologies for the development of Akt/PKB inhibitors. These technologies are helpful in the development of specific and more effective targeted therapies. For instance, Denovo Biopharma LLC has developed a technology to design new clinical trials for the failed drug candidates due to their undesirable adverse effects. The technology is enabling the drug candidate to be used in lower dose for small and targeted patient population. The key objective of this technology is to identify novel biomarkers by scanning human genome to design a specific study for targeted population.

Some of the key players involved in the development of Akt/PKB inhibitors include F. Hoffman-La-Roche Ltd, Eli Lilly & Company, Merck & Co. Inc., Novartis AG, Denovo Biopharma LLC, Diffusion Pharmaceuticals Inc., Astex Pharmaceuticals, ArQule Inc., Cotinga Pharmaceuticals Inc., and Oneness Biotech Co. Ltd.

Read More

Increasing Geriatric Population Resulting in Clinical Decision Support System (CDSS) Market Advance

The rising demand for advanced healthcare services and remote patient monitoring systems, investments by healthcare information technology (HIT) firms, and support from government organizations are driving the adoption of clinical decision support system (CDSS). From $410.5 million in 2015, the CDSS market is projected to grow at a CAGR of 21.5% during 2016–2022. CDSS is an HIT system, which helps doctors and other medical professionals with clinical decision making, thereby improving the quality of healthcare and patient outcomes.

To learn more about this report@ http://bit.ly/37XTcec

Of the two types of solutions available — integrated and standalone — integrated solutions dominated the CDSS market during the historical period (2012–2015). Such solutions are also expected to witness the higher CAGR, of 22.4%, during the forecast period, as these are integrated with electronic health records (EHR) and computerized physician order entry (CPOE) systems, especially those that relate to drug allergy alerts, drug–drug interactions, and clinical reminders. As integrated systems help prevent medication errors, the demand for these is growing.

The increasing support for the technology from governments is also helping the market grow. For instance, under the Connecting Europe Facility, the European Union granted around $18.1 million for deploying digital service infrastructures (DSI) in the eProcurement, eHealth, online dispute resolution (ODR), and eIdentification (eID) areas. Similarly, the U.S. government has implemented the Health Information Technology for Economic and Clinical Health (HITECH) Act, which mandates the use of digital health technologies.

During the historical period, North America held the largest share in the CDSS market, in terms of value, and the same scenario is expected during the forecast period. This would be a result of the advanced healthcare infrastructure, growing geriatric population, increasing healthcare spending, and rising incidence of chronic and lifestyle-associated diseases here. As per the American Diabetes Association, the number of diabetes patients in the U.S. rose from 25.8 million in 2010 to about 29.1 million in 2012.

Therefore, with the increase in the geriatric population, which is more prone to chronic diseases and also unable to visit hospitals regularly, the demand for clinical decision support systems will continue rising.

Read More

Dry Eye Syndrome Therapeutics Analysis, Clinical Trials and Developments

Dry eye syndrome therapeutics currently exhibits a proliferating pipeline of 50+ therapeutic candidates.

According to the research, most of the therapeutic drug candidates are being developed for topical administration. It has been found that topical route of administration is easy to use, non-invasive, and ensures high level of patient satisfaction, and therefore, improves patient compliance.

The companies who are involved in developing therapeutics for dry eye syndrome have shown positive clinical results in the various phases of drug development. For instance, HL036, an anti- tumor necrosis factor (TNF) biobetter antibody, is being developed by HanAll BioPharma in collaboration with Harbour BioMed for the treatment of inflammatory diseases. The results from the Phase II clinical trials of the drug candidate, showed statistically significant improvement of the symptoms, in the patients with dry eye syndrome.

Moreover, in September 2017, Redwood Pharma AB contracted the Swiss contract research organization (CRO) CROss Alliance for the management of a clinical Phase II clinical trial of the drug candidate, RP101, in patients with chronic dry eye disease.

TopiVert Pharma Limited, Redwood Pharma AB, HanAll BioPharma, Takeda Pharmaceutical Company Limited, Mitotech SA, Harbour BioMed, and Samjin Pharm Co. Ltd. are some of the key companies involved in the development of dry eye syndrome therapeutics.

Read more: https://www.pharmaproff.com/report/dry-eye-syndrome-therapeutics-pipeline-analysis

Read More

Psoriasis Therapeutics Analysis, Clinical Trials and Developments

Psoriasis is identified as a condition which causes chronic inflammation and scaling on skin. It develops when skin cells grow rapidly below the surface of the skin and get deposited on the surface before they get matured. In general, this deposition of cells takes a month time however, in psoriasis it may occur within few days. Development of thick patches of inflamed skin with a silvery scale covering starts to appear on skin. These patches are also referred to as plaques as they itch and feel sore. The commonly affected areas are knees, elbows, other parts of the legs, lower back, scalp, soles of feet, face and palms. Psoriasis can also affect toenails, fingernails, inside the mouth and soft tissues of genitals. The most common types of psoriasis are plaque psoriasis, inverse psoriasis, and pustular psoriasis. The disease is generally diagnosed using a skin biopsy.

Currently, there is no cure for psoriasis; however, there are several symptomatic treatment options available to improve the quality of life of patients. These medical options include topical treatment (corticosteroids, retinoids, and vitamin D analogs), phototherapy (ultraviolet B and photochemotherapy), and systemic medication (methotrexate, acitretin, cyclosporine, etanercept, and infliximab). Moreover, lifestyle modifications, such as diet and alternative therapies are also common components of psoriasis treatment regimens.

Pre-Purchase Inquiry at: https://www.pharmaproff.com/enquiry/1248

According to the research findings, majority of the pipeline drug candidates are being developed for topical administration. It has been found that the topical route of administration is easy to use, non-invasive, and ensures high level of patient satisfaction, and thus, improves patient’s compliance toward medications for the treatment of the disease.

In January 2018, Monash University collaborated with Janssen Global Services LLC (a subsidiary of Johnson & Johnson) to investigate factors that lead to immune-mediated disease, psoriasis, and discover new treatments for the disease prevention. Therefore, by leveraging the Monash University’s technological capabilities, the company extended a three-year research program for the development of various novel approaches for the treatment of autoimmune disease. Moreover, in September 2015, NuMedii Inc. collaborated with Allergan plc to explore new therapeutic options for the treatment of psoriasis.

Novartis AG, AbbVie Inc., Celgene Corporation, Eli Lilly and Company, Pfizer Inc., Johnson & Johnson, and LEO Pharma A/S are some of the major key players involved in the development of psoriasis therapeutics.

Read More

Tissue Diagnostics Market Size, Leading Players, Segments Analysis and Forecast Report 2024

A recent trend observed in the tissue diagnostics industry is increasing usage of immunohistochemistry products as companion diagnostics devices. Increasing prevalence of cancer has fuelled the demand of better diagnostic techniques, which could detect cancer in the earliest stage. According to the WHO, in 2012, there were 14 million new cancer cases and 8.2 million cancer related deaths worldwide.

The global tissue diagnostics market is categorized on the basis of product type, technology, application, and end-user. Based on product type, the tissue diagnostics market can be categorized as instruments and consumables. On the basis of technology, the tissue diagnostics market is categorized as digital pathology and workflow management, in situ hybridization, immunohistochemistry, and special staining. The immunohistochemistry segment leads the global tissue diagnostics market in terms of market size.

To Learn More About this report at: http://bit.ly/2Q76du2

Geographically, North America will be leading the global tissue diagnostics market in the coming years due to high prevalence of cancer cases, high healthcare expenditure, and presence of a large number of hospitals and pharmaceutical companies. Additionally, the legislative reform of Affordable Care Act in the U.S. is also expected to drive the North American market in the coming years.

Asia-Pacific is the fastest growing region in the global tissue diagnostics market. The major reasons for the fastest growth in the region are aging population, increasing disposable income, and improving healthcare infrastructure. Moreover, the tissue diagnostics marketis growing due to large unexplored tissue diagnostics market and large population base suffering with cancer in the emerging economies, such as India and China, of Asia-Pacific region.

Some of the major players operating in the global tissue diagnostics market are F. Hoffmann-La Roche AG., Sigma Aldrich Corporation, Abbott, Biogenex Laboratories, BioSB, Cell Signalling Technology Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, GE Healthcare, and Siemens Healthcare.

Read More

Weight Management Market Size, Share, Segment Analysis and Forecast Report 2024

The global weight management market size is growing significantly due to escalating technological advancement, increasing innovation in weight management ingredients, and increasing prevalence of obesity. According to National Health and Nutrition Examination Survey (NHANES) in 2009-10, more than 78 million U.S. adults were obese. Similarly, as per World Health Organization (WHO), approximately 2.8 million people die each year due to obesity.

The weight management market is categorized on the basis of diet and equipment. On the basis of diet, the market can be categorized as meals, supplements, and beverages. Diet leads the market due to increasing prevalence of obese cases, technological advancement and increasing health consciousness of people. The meals can be further segmented as meal replacement, organic food and others; whereas, supplements can be segmented as protein, fiber and others.

To Learn More About this report at: http://bit.ly/38Z2l7h

On the basis of equipment, the market can be categorized as fitness equipment, and surgical equipment. The fitness equipment includes cardiovascular training equipment and strength training equipment. The cardiovascular training equipment leads the market under fitness equipment category. The surgical equipment further includes minimally invasive surgical equipment and non-invasive surgical equipment. Minimally invasive surgical equipment includes gastric bypass surgery, laparoscopic adjustable gastric banding system, laparoscopic sleeve gastrectomy, and others. Non-invasive surgical equipment includes intragastric balloon systems, endoscopic stapling, endobarrier and others.

Asia-Pacific is the fastest growing region in the global weight management market. The major reasons for the fastest growth of weight management market in the region are increasing medical tourism, large pool of patients, and increasing healthcare expenditure. Moreover, the weight management market is growing due to increasing awareness of weight management, and refining healthcare infrastructure in the emerging countries, such as India and China, of Asia-Pacific region.

Global Weight Management Market Key Players:

• Amer Sports
• Technogym SPA
• Weight Watchers International Inc.
• Ediets.Com Inc.
• Jenny Craig Inc.
• Medtronic Inc.
• Kellogg Company
• Brunswick Corporation
• Jenny Craig Inc.
• Atkins Nutritionals Inc.
• Herbalife Ltd.
• Apollo Endosurgery Inc.
• Nutrisystem Inc.
• Cyber International, Inc.
• Johnson & Johnson.

Read More

Next-Generation Sequencing Market Size Will Make a Huge Impact in Near Future

The global next-generation sequencing market is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years.

The advanced research and development activities by the major players are propelling the demand for cost effective and efficient next-generation sequencing platforms. However, interpretation of large volume of complex sequencing data through next-generation sequencing platforms is a major challenge in global next-generation sequencing market.

The global next-generation sequencing market is categorized as technology type, sequencing workflow, applications, and end-users. Based on technology type, the next-generation sequencing market is categorized as pyrosequencing, ion-semiconductor sequencing, sequencing by synthesis, single molecule realtime sequencing, and sequencing by ligation. The sequencing by synthesis segment leads the global next-generation sequencing market. Based on sequencing workflow, the next-generation sequencing market is categorized as next-generation pre-sequencing, next-generation sequencing platforms, and next-generation sequencing services.

Inquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=next-generation-sequencing-market

Based on applications, the next-generation sequencing market can be categorized as diagnostics, drug discovery, animal and agriculture research, personalized medicine, and others. End-users of next-generation sequencing include academic and research institutes, biopharmaceutical and biotechnology companies, hospitals, and others. Academic and research institutes lead the global next-generation sequencing market.

Some of the major players operating in the global next-generation sequencing market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Biomatters, Ltd., GATC Biotech AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd, Macrogen, Inc. among others.

Read More

Latin America Wound Dressing Market Size, Regional Analysis, Key Players and Future Scope

A recent P&S Intelligence study has estimated the 2024 value of the Latin America wound dressing market to be $400.9 million. The key drivers of the domain’s growth are rising prevalence of diabetes, growing geriatric population and number of patients with chronic wounds, and high brain injury rate.

When segmented by type, the domain can be categorized into traditional dressings and advanced dressings. In 2018, the advanced dressings category is estimated to account for more than 60.0% share in the LATAM wound dressing market due to the rising utilization of such products in complex application areas as well as the growing number of people with chronic diseases. Advanced dressings further consist of the hydrocolloids, foams, alginates, films, collagen, hydrogels, wound contact layers, superabsorbent, hydrofiber, and others subcategories. Among all these, foam dressings are the most preferred type of advanced dressing in the Latin American region.

Both, acute and chronic wounds, can be managed with wound dressing. Now, chronic wounds consume more dressing material compared to the acute type due to their more severe nature. It is being estimated that the wound dressing demand for chronic wounds will contribute a $200 million revenue to the Latin America (LATAM) wound dressing market in 2018. Coming to the acute wounds category, it is further subdivided into burns, and surgical and traumatic wounds. Of these, the surgical and traumatic wounds subdivision is expected to generate the larger revenue in 2018 (91.0% share).

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=latam-wound-dressing-market

The domain is expected to grow the most in Brazil during the forecast period, primarily due to government research and development programs and increasing chronic injury incidents in the country. For instance, Brazilian Synchrotron Light Laboratory carried out a research, according to which nitric oxide (NO) may prove effective as a dressing material ingredient for chronic wounds. The research seeks to develop a product based on the use of supramolecular poly (acrylic acid) hydrogel, which contains an NO donor in the form of S-nitrosoglutathione along with the nanometric micelles of another polymer.

LATAM wound dressing market players, such as DeRoyal Industries Inc., Hollister Incorporated, Smith & Nephew plc, Johnson & Johnson, 3M Company, Mölnlycke Health Care AB, BSN Medical GmbH, Acelity L.P. Inc., Coloplast A/S., B. Braun Melsungen AG, and HARTMANN GROUP., are benefiting from product approvals in the region.

Read More

DNA Sequencing Market Trends, Business Strategies and Opportunities with Key Players Analysis 2024

The global DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2023). This is attributed to the extensive use of consumables for sample preparation, cluster generation, and other processes during the course of experiments.

The key trends observed in the DNA sequencing industry are surge in clinical assessment through personalized genomics, increase in oncological research, demand for easy and fast clinical diagnosis, and adoption of high throughput technology.

Various factors leading to the growth of the DNA sequencing industry include the rise in technological advancements, increase in collaborations & partnerships of key players, and global increase in genome mapping programs. Additionally, rise in R&D investment also enhances the growth of the market and provides lucrative opportunities to the key players. Some of the challenges hindering the growth of the market are concerns related to the accuracy & standardization, along with the ethical & legal limitations posed with DNA sequencing.

Download report sample at: https://www.psmarketresearch.com/market-analysis/dna-sequencing-market/report-sample

The DNA sequencing industry provides immense opportunities for the new players to grow, due to the eminence of latest innovative technology in the market. Subsequently, the key players are also exploring opportunities by leveraging their precedence in technological advancement. The advent of next generation DNA sequencing (NGS) also provides opportunities for the market players to grow in the future.

Some of the key players in the global market include Illumina, Inc, Pacific Biosciences of California, Inc., Siemens AG, ZS Genetics, Inc, Abbott Laboratories, Li-Cor, Inc., F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies, and Agilent Technologies, Inc.

Read More

How is Unhealthy Lifestyle of People Driving Complementary and Alternative Medicines Market?

Due to globalization and urbanization, the lifestyle of people across the world has changed drastically. At the present time, a large number of people are suffering from medical conditions such as stress, obesity, hypertension, and insomnia. For instance, as per the Our World in Data, in 2017, 3.4% and 3.8% people across the globe were suffering from anxiety and depression, respectively. Apart from this, the prevalence of chronic diseases is on the rise as well; for example, the number of people suffering from diabetes grew from 108 million in 1980 to 422 million in 2014, according to the World Health Organization (WHO). The symptoms of these medical conditions can be managed by alternative therapies and medicines, including meditation, yoga, and tai chi, which is why the demand for complementary and alternative medicines (CAM) is rising.

The remedies or treatments that are used in place of conventional medical treatments, such as chemotherapy, surgery, allopathic medicines, and radiation therapy, are called CAM. Some examples of CAM are chiropractic, acupuncture, traditional medicine (herbal and ayurvedic), yoga, reiki, and homeopathy.

To Learn More About this Report at: http://bit.ly/35RBbg4

As per a research conducted by P&S Intelligence, in 2018, the global complementary and alternative medicines market reached a value of $192.0 billion and is predicted to register a 6.0% CAGR in the near future. The various types of CAM are mind-body intervention-based, nature-based, energy-based, and manipulative body-based. Among all these, the largest demand was created for nature-based CAM during 2014–2018. This was attributed to the increased requirement for organic and natural medications, which have less side-effects as compared to allopathic drugs. Ayurveda, mud therapy, and homeopathy are primary types of nature-based CAM.

One of the key reasons for the growing demand for CAM is the side-effects associated with allopathic medications. Several incidents of side-effects, such as diarrhea, vomiting, internal bleeding, dizziness, seizure, and insomnia, have been reported by patients taking allopathic medicines. For instance, aspirin, one of the most common drugs, is believed to cause side-effects including vomiting, heartburn, and seizures. These side-effects can happen because of various reasons, such as drug-food interaction and drug-drug interaction. Attributed to these factors, the consumers have started adopting alternative therapies and medicines, as they help in the management of several diseases without any major side-effects.

Read More